Biotech: The Ultimate Impact Investment? | TIGER 21 Chair Featured in Financial Times
Share on Social
Orlando TIGER 21 Chair Eric Casaburi was recently featured in the Financial Times, where he shared his insights on how the ultra-high-net-worth community is currently approaching biotech investing and the tremendous movement into the healthcare space. A survey of TIGER 21 Members found that nearly 25% planned to invest in healthcare this year.
The emphasis on healthcare is reflected in the flow of family office money into venture capital. Despite the potential risk if a treatment does not work, the rewards in healthcare can be substantial, making it an impact investment.
About TIGER 21
TIGER 21 is an exclusive global community of ultra-high-net-worth entrepreneurs, investors, and executives.
Explore the TIGER 21 Member ExperienceTags
Member Insight Reports
Download the Asset Allocation Report to see the latest Member portfolio data.
Download ReportLife After Selling a Business: What to expect, what you might not expect, and what’s next.
View the Report
Member Insights
Wealth Preservation
Life After Exit
Member Insights
